-
-
-
-
-
-
-
Iovance Biotherapeutics (IOVA) Misses Q2 EPS by 5c, reiterates guidance
-
-
-
-
-
-
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
-
-
-
-
-
-
-
IOVA SHAREHOLDER NOTICE: Iovance Biotherapeutics Investors are Notified to Contact BFA Law about the Pending Class Action Lawsuit by July 14
-
-
-
-
-
-
-
Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - IOVA
-
-
-
-
-
-
-
IOVA CLASS DEADLINE: Iovance Biotherapeutics Shareholders that Suffered Losses are Reminded to Contact BFA Law by Upcoming July 14 Court Deadline
-
-
-
-
-
-
-
Levi & Korsinsky Reminds Iovance Biotherapeutics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 14, 2025 - IOVA
-
-
-
-
-
-
-
IOVANCE FRAUD: BFA Law Reminds Iovance Biotherapeutics, Inc. (IOVA) Investors with Losses to Contact the Firm Prior to the July 14 Class Action Deadline
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

